Literature DB >> 2157581

A comparison of seven-point and visual analogue scales. Data from a randomized trial.

R Jaeschke1, J Singer, G H Guyatt.   

Abstract

Many controlled trials rely on subjective measures of symptoms or quality of life as primary outcomes. The relative merits of different response options for these instruments is an important issue. Therefore, we compared the responsiveness and validity of seven-point versus visual analogue scales (VAS) in a questionnaire measuring quality of life in chronic heart failure in a double-masked crossover trial of digoxin versus placebo. The VAS and seven-point scale versions of the questionnaire were administered to 20 patients during 7 weeks on digoxin and 7 weeks on placebo. The order of administration of the questionnaires was determined by random allocation. The ability of the two methods to distinguish digoxin and placebo, and their correlation with other measures, were comparable. We conclude that the two methods of presenting response options show comparable responsiveness and validity in a randomized trial setting. The ease of administration and interpretation of the seven-point scale recommend its use.

Entities:  

Mesh:

Year:  1990        PMID: 2157581     DOI: 10.1016/0197-2456(90)90031-v

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  34 in total

1.  Design of treatment trials for functional gastrointestinal disorders.

Authors:  S J Veldhuyzen van Zanten; N J Talley; P Bytzer; K B Klein; P J Whorwell; A R Zinsmeister
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.

Authors:  E F Juniper; G H Guyatt; R S Epstein; P J Ferrie; R Jaeschke; T K Hiller
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

3.  Daily spinal mechanical loading as a risk factor for acute non-specific low back pain: a case-control study using the 24-Hour Schedule.

Authors:  Eric W P Bakker; Arianne P Verhagen; Cees Lucas; Hans J C M F Koning; Rob J de Haan; Bart W Koes
Journal:  Eur Spine J       Date:  2006-04-29       Impact factor: 3.134

4.  Impact of mass screening for gluten-sensitive enteropathy in working population.

Authors:  Meritxell Mariné; Fernando Fernández-Bañares; Montserrat Alsina; Carme Farré; Montserrat Cortijo; Rebeca Santaolalla; Antonio Salas; Margarita Tomàs; Elias Abugattas; Carme Loras; Ingrid Ordás; Josep-M Viver; Maria Esteve
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

5.  Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy.

Authors:  P Lähteenmäki; M Haukkamaa; J Puolakka; U Riikonen; S Sainio; J Suvisaari; C G Nilsson
Journal:  BMJ       Date:  1998-04-11

6.  Comparison of conditional quality of life terminology and visual analogue scale measurements.

Authors:  S M Grunberg; S Groshen; S Steingass; S Zaretsky; B Meyerowitz
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

7.  Is Enhanced Recovery the New Standard of Care in Microsurgical Breast Reconstruction?

Authors:  Anoushka Afonso; Sabine Oskar; Kay See Tan; Joseph J Disa; Babak J Mehrara; Jihan Ceyhan; Joseph H Dayan
Journal:  Plast Reconstr Surg       Date:  2017-05       Impact factor: 4.730

8.  Individualized chiropractic and integrative care for low back pain: the design of a randomized clinical trial using a mixed-methods approach.

Authors:  Kristine K Westrom; Michele J Maiers; Roni L Evans; Gert Bronfort
Journal:  Trials       Date:  2010-03-08       Impact factor: 2.279

9.  Comparison of anchor-based and distributional approaches in estimating important difference in common cold.

Authors:  Bruce Barrett; Roger Brown; Marlon Mundt
Journal:  Qual Life Res       Date:  2007-11-20       Impact factor: 4.147

10.  Canadian Physiotherapy Assessment of Clinical Performance: Face and Content Validity.

Authors:  Brenda Mori; Kathleen E Norman; Dina Brooks; Jodi Herold; Dorcas E Beaton
Journal:  Physiother Can       Date:  2016       Impact factor: 1.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.